| LOGIVIK CHUGAI SEIYAKU KABUSHIKI KAISHA
1242505 04 Jan 2005 | on 13 Oct 2010 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely an anti-interleukin-6 (IL-6) receptor monoclonal antibody for the treatment of cancer, diabetes, renal failure, cardiovascular diseases, cerebrovascular diseases, respiratory diseases, hematopoietic disorders, bone diseases, systemic lupus erythematosus (SLE), rheumatoid arthritis, juvenile idiopathic arthritis (JIA), Crohn disease, Castlemans disease, spinal cord injury, Stills disease, autoimmune diseases and multiple myeloma. | | 
